T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Texas Roadhouse
TXRH
$13.6B
| $48.5M | 0.01% |
663,060
-7,769
| -1% | -$610K |
|
|
CDK
877
DELISTED
CDK Global, Inc.
CDK
| $48.5M | 0.01% |
885,698
+1,620
| +0.2% | +$87.6K |
|
|
THR
878
DELISTED
Thermon Group Holdings
THR
| $48.5M | 0.01% |
3,450,988
-20,307
| -0.6% | -$313K |
|
879
Herc Holdings
HRI
$5.64B
| $48.5M | 0.01% |
537,820
+79,311
| +17% | +$9.53M |
|
880
Allstate
ALL
$65.9B
| $48.3M | 0.01% |
381,066
-53,077
| -12% | -$6.95M |
|
881
Performance Food Group
PFGC
$16.4B
| $48.2M | 0.01% |
1,048,601
+15,362
| +1% | +$709K |
|
882
Green Dot
GDOT
$770M
| $48.2M | 0.01% |
1,918,976
+202,042
| +12% | +$5.47M |
|
|
CHUY
883
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $48.1M | 0.01% |
2,415,087
-5,123
| -0.2% | -$118K |
|
884
Digital Realty Trust
DLR
$73.1B
| $48M | 0.01% |
370,077
-38,543
| -9% | -$5.32M |
|
885
Iovance Biotherapeutics
IOVA
$2.95B
| $48M | 0.01% |
4,350,685
-805,961
| -16% | -$10.6M |
|
886
Merit Medical Systems
MMSI
$5.4B
| $48M | 0.01% |
883,846
+6,307
| +0.7% | +$385K |
|
887
Nkarta
NKTX
$165M
| $47.8M | 0.01% |
3,879,662
+1,520,473
| +64% | +$20M |
|
888
BlackLine
BL
$1.82B
| $47.6M | 0.01% |
715,319
+524,773
| +275% | +$35.9M |
|
889
VanEck Gold Miners ETF
GDX
$26.9B
| $47.6M | 0.01% |
1,739,575
+232,387
| +15% | +$7.84M |
|
890
Invesco
IVZ
$14.3B
| $47.4M | 0.01% |
2,940,475
+124,108
| +4% | +$2.35M |
|
891
Kadant
KAI
$3.91B
| $47.3M | 0.01% |
259,359
+7,231
| +3% | +$1.35M |
|
|
IGMS
892
DELISTED
IGM Biosciences
IGMS
| $47.3M | 0.01% |
2,622,873
+376,832
| +17% | +$6.72M |
|
893
Aflac
AFL
$60.7B
| $47.2M | 0.01% |
852,436
-104,176
| -11% | -$6.15M |
|
894
Prudential Financial
PRU
$43B
| $47.1M | 0.01% |
492,256
-58,185
| -11% | -$6.16M |
|
895
Maravai LifeSciences
MRVI
$861M
| $46.8M | 0.01% |
1,647,627
-401,330
| -20% | -$12.7M |
|
896
SL Green Realty
SLG
$4.08B
| $46.7M | 0.01% |
1,012,411
+184,761
| +22% | +$11.8M |
|
897
Delta Air Lines
DAL
$60B
| $46.7M | 0.01% |
1,612,504
+353,987
| +28% | +$13.5M |
|
898
Azenta
AZTA
$1.49B
| $46.5M | 0.01% |
644,961
-22,433
| -3% | -$1.68M |
|
|
CIR
899
DELISTED
CIRCOR International, Inc
CIR
| $46.5M | 0.01% |
2,836,119
| – | – |
|
900
iShares Core US Aggregate Bond ETF
AGG
$138B
| $46.4M | 0.01% |
456,104
+385,850
| +549% | +$39.6M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.